Dr. Nathaniel Katz | Chief Science Officer, Analgesic Solutions

Dr. Nathaniel Katz is considered one of the leading experts of treatment and clinical study design in pain clinical trials. He is a neurologist and pain management specialist with a distinguished career at Harvard Medical School, Brigham & Women’s Hospital and Dana Farber Cancer Institute. He founded Analgesic Solutions with the mission of modernizing the design and conduct of pain clinical trials to advance the “scientific quality” of pain clinical research, and empower effective treatments for patients. He serves as the Chief Science Officer of Analgesic Solutions.

  • To Mitigate Placebo Response, Test, Train and Control Expectations

    To Mitigate Placebo Response, Test, Train and Control Expectations

    The placebo effect: it’s the curse of clinical trials across indications. Luckily, training patients to accurately report their symptoms has been proven to reduce placebo response.

    Read Post
  • loading
    Loading More...